During the last session, CryoPort Inc (NASDAQ:CYRX)’s traded shares were 0.36 million, with the beta value of the company hitting 1.63. At the end of the trading day, the stock’s price was $7.15, reflecting an intraday gain of 7.36% or $0.49. The 52-week high for the CYRX share is $20.10, that puts it down -181.12 from that peak though still a striking 25.59% gain since the share price plummeted to a 52-week low of $5.32. The company’s market capitalization is $353.30M, and the average intraday trading volume over the past 10 days was 0.3 million shares, and the average trade volume was 529.56K shares over the past three months.
CryoPort Inc (CYRX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.20. CYRX has a Sell rating from 0 analyst(s) out of 4 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CryoPort Inc (NASDAQ:CYRX) trade information
CryoPort Inc (CYRX) registered a 7.36% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 7.36% in intraday trading to $7.15, hitting a weekly high. The stock’s 5-day price performance is 3.77%, and it has moved by -9.15% in 30 days. Based on these gigs, the overall price performance for the year is -24.89%. The short interest in CryoPort Inc (NASDAQ:CYRX) is 2.82 million shares and it means that shorts have 6.28 day(s) to cover.
The consensus price target of analysts on Wall Street is $16.5, which implies an increase of 56.67% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8 and $52 respectively. As a result, CYRX is trading at a discount of -627.27% off the target high and -11.89% off the low.
CryoPort Inc (CYRX) estimates and forecasts
Statistics show that CryoPort Inc has underperformed its competitors in share price, compared to the industry in which it operates. CryoPort Inc (CYRX) shares have gone down -55.17% during the last six months, with a year-to-date growth rate less than the industry average at -17.02% against 4.90.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -45.48%. While earnings are projected to return -12.76% in 2024.
CYRX Dividends
CryoPort Inc is due to release its next quarterly earnings on 2024-Nov-07. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
CryoPort Inc (NASDAQ:CYRX)’s Major holders
CryoPort Inc insiders own 2.50% of total outstanding shares while institutional holders control 106.50%, with the float percentage being 109.23%. BROWN CAPITAL MANAGEMENT LLC is the largest shareholder of the company, while 226.0 institutions own stock in it. As of 2024-06-30, the company held over 6.19 million shares (or 12.5378% of all shares), a total value of $42.75 million in shares.
The next largest institutional holding, with 4.69 million shares, is of MORGAN STANLEY’s that is approximately 9.5133% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $32.44 million.
